Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4249395
Max Phase: Preclinical
Molecular Formula: C58H104N18O9
Molecular Weight: 1197.59
Molecule Type: Small molecule
Associated Items:
ID: ALA4249395
Max Phase: Preclinical
Molecular Formula: C58H104N18O9
Molecular Weight: 1197.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc1ccc(C(=N)N)cc1)C(C)C
Standard InChI: InChI=1S/C58H104N18O9/c1-32(2)28-43(69-37(11)77)52(81)73-45(30-34(5)6)54(83)75-46(31-35(7)8)55(84)74-44(29-33(3)4)53(82)71-42(18-15-26-68-58(64)65)51(80)76-47(36(9)10)56(85)72-41(16-12-13-24-59)50(79)70-40(17-14-25-67-57(62)63)49(78)66-27-23-38-19-21-39(22-20-38)48(60)61/h19-22,32-36,40-47H,12-18,23-31,59H2,1-11H3,(H3,60,61)(H,66,78)(H,69,77)(H,70,79)(H,71,82)(H,72,85)(H,73,81)(H,74,84)(H,75,83)(H,76,80)(H4,62,63,67)(H4,64,65,68)/t40-,41-,42-,43+,44-,45-,46-,47-/m0/s1
Standard InChI Key: KJVZAJGSDBZBEC-LQXMKOPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1197.59 | Molecular Weight (Monoisotopic): 1196.8234 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):